6533b854fe1ef96bd12af4db

RESEARCH PRODUCT

MOESM1 of Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study

H. LiBruce ZurawHilary LonghurstMarco CicardiKonrad BorkJames BakerWilliam LumryJonathan BernsteinMichael ManningDonald LevyMarc RiedlHenrike FeuersengerSubhransu PrustyIngo PragstThomas MachnigTimothy Craig

subject

description

Additional file 1: Table S1. Patients Aâ D with <50% reduction in HAE attack rate treated with 60 IU/kg C1-INH (SC).

https://dx.doi.org/10.6084/m9.figshare.9745997.v1